Telogen Effluvium and Alopecia Rates High in GLP-1 RA Users
Real-world data showed high incidence of hair loss among GLP-1 receptor agonist users, but the phenomenon is probably an unmasking, rather than a direct effect. Medscape Medical News
Eli Lilly claims its GLP-1 outperforms semaglutide in trial
Eli Lilly said its experimental oral GLP-1 drug orforglipron outperformed Novo Nordisk’s oral semaglutide in a head-to-head phase 3 trial. In a 52-week study involving 1,698 adults with Type 2 diabetes, the highest dose of orforglipron lowered average blood sugar by 2.2%, compared with 1.4% for the highest dose of oral semaglutide, according to a […]
New weight loss jab ‘is more effective than Ozempic and Mounjaro’ – ‘reprogramming how the body handles fat and energy’
A NEW type of fat jab is being trialled on humans for the first time. Inventors claim they can modify RNA genetic material to rewire the metabolism and aid weight loss without dieting. The new jab looks to tackle the root causes of obesity instead of simply switching off hungerGetty The experimental injection, made by […]
CDC vaccine panel vote has lawmakers, former staff on edge
Click in for more news from The Hill {beacon} Health Care The Big Story CDC vaccine panel vote has lawmakers, former staff on edge Health Secretary Robert F. Kennedy Jr.’s remade CDC vaccine advisory panel is set to meet Thursday and Friday. Changes to the schedule of childhood vaccinations are anticipated. © AP The […]
Lilly says its experimental GLP-1 pill better than Novo’s Rybelsus in diabetes study – Reuters
Lilly says its experimental GLP-1 pill better than Novo’s Rybelsus in diabetes study Reuters
Weight loss drugs could add years to Americans’ lives, researchers project
A new study has discovered that drugs for diabetes and weight loss could significantly reduce mortality for Americans. Researchers at Swiss Re, a reinsurance company in Zurich, Switzerland, released estimations that GLP-1 drugs could lead to a 6.4% reduction in all-cause mortality in the U.S. by 2045. In the U.K., more than a 5% reduction […]
Protein snacks are getting more popular thanks to weight-loss drugs, says General Mills
While people on GLP-1 drugs are reducing their overall calories, the packaged-foods producer says they have a growing hunger for protein as they lose muscle mass.
‘Prolific’ Regeneron won’t stop with phase III FOP data drop
“People have some inability to focus on [Regeneron Pharmaceuticals Inc.’s] pipeline,” which stands as “the most prolific in the industry, I would dare to say,” CEO Leonard Schleifer remarked during the Morgan Stanley health care conference Sept. 8. Most recently, Regeneron bragged on two prospects. The ultra-rare disease fibrodysplasia ossificans progressiva (FOP) took center stage […]
GLP-1 RAs Cost-Effective Versus Usual Care for Knee OA, Obesity
WEDNESDAY, Sept. 17, 2025 — Compared with usual care, the glucagon-like peptide 1 receptor agonists (GLP-1 RAs) tirzepatide and semaglutide are cost-effective for people with knee osteoarthritis (OA) and obesity, according to a study published…
Wednesday links: following the playbook
Markets Mortgage rates are at their lowest level of the year. (resiclubanalytics.com) The price of Bitcoin has been pretty steady of late. (axios.com) Recent IPOs are seeing some relative strength. (capitalspectator.com) Finance Earning reports don’t need to be quarterly, but it requires more trust in management. (advisorperspectives.com) Why are financial firms tightening up their non-compete […]